HENRY H. WASHINGTON III, PHD, was in the U.S. Army for 25 years before he retired. But as it turned out, his transition from military service to civilian life came with prostate cancer.
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
Data from Vista Health, a leading UK provider of private diagnostic services, has revealed the worrying knowledge gap when it comes to the prostate, as 26 percent of men do not know what their ...
Across the UK, pub bells will ring early for the final time this Wednesday as part of a new campaign by Greene King and Macmillan Cancer Support ...
Thirty-six progressive mCRPC patients received TLX591-Tx across three cohorts (enzalutamide, abiraterone, or docetaxel sequence), and all completed two planned doses without emergent, unexpected ...
Eating a vegetarian diet can help lower your risk of five kinds of cancers, according to a recent study. The study published Feb. 27 by the British Journal of Cancer analyzed data from 1.8 million ...
No increased risk for thrombosis or bleeding seen with concurrent use of enzalutamide, apalutamide, or abiraterone with DOACs.
Cast urge men to get checked for prostate cancer.
Pubs are ringing their bells at 6pm as part of a campaign to raise awareness of the one in six blokes in the UK who will be diagnosed with prostate cancer in their lifetime. Greene King and Macmillan ...
Investing.com-- Shares of Telix Pharmaceuticals (ASX:TLX) jumped on Tuesday after the company reported positive results from a late-stage trial of its experimental prostate cancer therapy.
Isaac Dingle will have some heartbreaking fears on Emmerdale after he was told that his father, Cain, had been diagnosed with prostate cancer. With Kyle Winchester being told at the same time, how ...
J&J JNJ announced that the European Commission has approved its precision therapy, Akeega (niraparib and abiraterone acetate dual action tablet), for expanded use in prostate cancer. The regulatory ...